{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T22:25:01Z","timestamp":1749939901391},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathophysiology"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.pathophys.2007.02.001","type":"journal-article","created":{"date-parts":[[2008,5,17]],"date-time":"2008-05-17T04:45:09Z","timestamp":1210999509000},"page":"157-166","source":"Crossref","is-referenced-by-count":9,"title":["Matrix metalloproteinase-9 in spontaneously hypertensive hyperlipidemic rats"],"prefix":"10.1016","volume":"15","author":[{"given":"Yasuhiko","family":"Asano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Iwai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masako","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Kumai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunari","family":"Munemasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeko","family":"Oonuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamoru","family":"Tadokoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuji","family":"Oguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathophys.2007.02.001_bib1","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1161\/01.CIR.90.4.2126","article-title":"Mechanisms leading to myocardial infarction: insights from studies of vascular biology","volume":"90","author":"Fuster","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.pathophys.2007.02.001_bib2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2796.1994.tb01123.x","article-title":"Determinants of femoral and carotid artery atherosclerosis","volume":"236","author":"Joensuu","year":"1994","journal-title":"J. Int. Med."},{"key":"10.1016\/j.pathophys.2007.02.001_bib3","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ophtha.2004.10.039","article-title":"Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: the atherosclerosis risk in communities & cardiovascular health studies","volume":"112","author":"Wong Larsen","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.pathophys.2007.02.001_bib4","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0161-6420(82)34664-3","article-title":"Hypertensive retinopathy. Description, classification, and prognosis","volume":"89","author":"Walsh","year":"1982","journal-title":"Ophthalmology"},{"key":"10.1016\/j.pathophys.2007.02.001_bib5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/bmb\/ldh050","article-title":"Hypertensive retinopathy signs as risk indicators of cardiovascular morbidity and mortality","volume":"73","author":"Wong","year":"2005","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.pathophys.2007.02.001_bib6","first-page":"257","article-title":"Reduced hepatic drug-metabolizing enzyme activities in spontaneously hyperlipidemic rat as an animal model of hypercholesterolaemia","volume":"24","author":"Watanabe","year":"1996","journal-title":"Med. Sci. Res."},{"key":"10.1016\/j.pathophys.2007.02.001_bib7","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1046\/j.1440-1681.2003.03872.x","article-title":"Biochemical and morphological characterization of spontaneously hypertensive hyperlipidaemic rats","volume":"30","author":"Kumai","year":"2003","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.pathophys.2007.02.001_bib8","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.lfs.2003.09.051","article-title":"Anti-lipid deposition effect of HMG-CoA reductase inhibitor, pitavastatin, in a rat model of hypertension and hypercholesterolemia","volume":"74","author":"Kumai","year":"2004","journal-title":"Life Sci."},{"key":"10.1016\/j.pathophys.2007.02.001_bib9","doi-asserted-by":"crossref","first-page":"21491","DOI":"10.1074\/jbc.274.31.21491","article-title":"Matrix metalloproteinases","volume":"274","author":"Nagase","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pathophys.2007.02.001_bib10","first-page":"111","article-title":"Tissue inhibitors of metalloproteinases: structure, regulation and biological functions","volume":"74","author":"Gomez","year":"1997","journal-title":"Eur. J. Cell. Biol."},{"key":"10.1016\/j.pathophys.2007.02.001_bib11","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1445-5994.2005.00822.x","article-title":"Elevated circulating levels of matrix metalloproteinase-9 and -2 in patients with symptomatic coronary artery disease","volume":"35","author":"Zeng","year":"2005","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.pathophys.2007.02.001_bib12","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1161\/01.ATV.0000151373.33830.41","article-title":"Matrix metalloproteinase-9 (MMP-9), MMP-2, and serum elastase activity are associated with systolic hypertension and arterial stiffness","volume":"25","author":"Yasmin","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.pathophys.2007.02.001_bib13","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0002-9440(10)64401-X","article-title":"Matrix metalloproteinase-9 contributes to choroidal neovascularization","volume":"161","author":"Lambert","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.pathophys.2007.02.001_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3164\/jcbn.33.23","article-title":"Inhibition of oxygen-induced retinal neovascularization in the neonatal rat by green tea extract","volume":"33","author":"Minami","year":"2003","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.pathophys.2007.02.001_bib15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/02713680600577780","article-title":"Activation of AP-1 and increased synthesis of MMP-9 in the rabbit retina induced by lipid hydroperoxide","volume":"31","author":"Iwai","year":"2006","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.pathophys.2007.02.001_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1538\/expanim.56.1","article-title":"Development of hyperfibrinogenemia in spontaneously hypertensive and hyperlipidemic rat: a potentially useful animal model as a complication of hypertension and hyperlipidemia","volume":"56","author":"Gomibuchi","year":"2007","journal-title":"Exp. Anim."},{"key":"10.1016\/j.pathophys.2007.02.001_bib17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.5551\/jat.12.191","article-title":"Enhancement of the coagulation system in spontaneously hypertensive and hyperlipidemic rats","volume":"12","author":"Amagasa","year":"2005","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.pathophys.2007.02.001_bib18","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1006\/exer.2001.1152","article-title":"Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats","volume":"74","author":"Zhang","year":"2002","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.pathophys.2007.02.001_bib19","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/oxfordjournals.jbchem.a021955","article-title":"Nitric oxide mediates interleukin-1-induced gene expression of matrix metalloproteinases and basic fibroblast growth factor in cultured rabbit articular chondrocytes","volume":"123","author":"Sasaki","year":"1998","journal-title":"J. Biochem."},{"key":"10.1016\/j.pathophys.2007.02.001_bib20","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.2337\/diacare.25.8.1320","article-title":"Blood pressure, lipids, and obesity are associated with retinopathy: the Hoorn Study","volume":"25","author":"Van Leiden","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pathophys.2007.02.001_bib21","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1167\/iovs.04-0069","article-title":"Associations between the metabolic syndrome and retinal microvascular signs: the atherosclerosis risk in communities study","volume":"45","author":"Wong","year":"2004","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.pathophys.2007.02.001_bib22","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1081\/CEH-120015348","article-title":"Neuroprotective effect of treatment with calcium antagonists on hypertensive retina","volume":"24","author":"Sabbatini","year":"2002","journal-title":"Clin. Exp. Hypertens."},{"key":"10.1016\/j.pathophys.2007.02.001_bib23","doi-asserted-by":"crossref","first-page":"R217","DOI":"10.1016\/S1074-5521(99)80081-7","article-title":"Molecular angiogenesis","volume":"6","author":"Kagsburn","year":"1999","journal-title":"Chem. Biol."},{"key":"10.1016\/j.pathophys.2007.02.001_bib24","first-page":"68","article-title":"Angiogenesis: state of the art","volume":"70","author":"Chao Han","year":"1999","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.pathophys.2007.02.001_bib25","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJM199405193302008","article-title":"The emerging concept of vascular remodeling","volume":"330","author":"Gibbsons","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pathophys.2007.02.001_bib26","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/01.RES.75.3.539","article-title":"Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat","volume":"75","author":"Bendeck","year":"1994","journal-title":"Circ. Res."},{"key":"10.1016\/j.pathophys.2007.02.001_bib27","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1161\/01.CIR.102.23.2861","article-title":"Remodeling of carotid artery is associated with increased expression of matrix metalloproteinases in mouse blood flow cessation model","volume":"102","author":"Godin","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.pathophys.2007.02.001_bib28","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/01.CIR.98.3.249","article-title":"Prevention of aneurysm development and rupture by local overexpression of plasminogen activator inhibitor-1","volume":"98","author":"Allaire","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.pathophys.2007.02.001_bib29","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1172\/JCI0215334","article-title":"Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms","volume":"110","author":"Longo","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.pathophys.2007.02.001_bib30","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1161\/01.CIR.99.14.1788","article-title":"Functional polymorphism in the region of geratinase B gene in relation to severity of coronary atherosclerosis","volume":"99","author":"Zhang","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.pathophys.2007.02.001_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.ATV.0000135656.49158.95","article-title":"Matrix metalloproteinase-9 influences large artery stiffness through effects on aortic gene and protein expression","volume":"24","author":"Medley","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.pathophys.2007.02.001_bib32","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/01.CIR.0000058700.41738.12","article-title":"Plasma concentrations and genetic variation of matrix metalloproteinase-9 and prognosis of patients with cardiovascular disease","volume":"107","author":"Blankenberg","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pathophys.2007.02.001_bib33","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/01.CIR.0000046451.38849.90","article-title":"Matrix metalloproteinase-9 pretreatment levels predicts intracranical hemorrhagic complications after thrombolysis in human stroke","volume":"107","author":"Motaner","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.pathophys.2007.02.001_bib34","first-page":"1256","article-title":"Matrix metalloproteinases and their inhibitors in human vitreous","volume":"39","author":"De La Paz","year":"1998","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.pathophys.2007.02.001_bib35","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00006982-200102000-00005","article-title":"Matrix metalloproteinases in human diabetic and nondiabetic vitreous","volume":"21","author":"Jin","year":"2001","journal-title":"Retina"},{"key":"10.1016\/j.pathophys.2007.02.001_bib36","first-page":"1524","article-title":"A prospective study of matrix metalloproteinases in proliferative vitreoretinopathy","volume":"39","author":"Kon","year":"1998","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.pathophys.2007.02.001_bib37","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.2337\/diabetes.47.8.1311","article-title":"Matrix metalloproteinase expression in human retinal microvascular cells","volume":"47","author":"Grant","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/j.pathophys.2007.02.001_bib38","first-page":"853","article-title":"TGF-beta increases retinal endothelial cell permeability by increasing MMP-9: Possible role of glial cells in endothelial barrier function","volume":"42","author":"Behzadian","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.pathophys.2007.02.001_bib39","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/35036374","article-title":"Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis","volume":"2","author":"Bergers","year":"2000","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.pathophys.2007.02.001_bib40","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.exer.2004.09.013","article-title":"Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood\u2013retinal and blood\u2013aqueous barrier breakdown","volume":"80","author":"Edelman","year":"2005","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.pathophys.2007.02.001_bib41","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/jcb.240530404","article-title":"Cytokine regulation of metalloproteinase gene expression","volume":"53","author":"Mauviel","year":"1993","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.pathophys.2007.02.001_bib42","doi-asserted-by":"crossref","first-page":"18786","DOI":"10.1074\/jbc.270.32.18786","article-title":"Tissue-specific enhancer-promoter interactions regulate high-level constitutive expression of matrix metalloproteinase 2 by glomerular mesangial cells","volume":"270","author":"Harendza","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pathophys.2007.02.001_bib43","first-page":"239","article-title":"Matrix metalloproteinase family","volume":"19","author":"Baramova","year":"1995","journal-title":"Cell. Biol. Int."},{"key":"10.1016\/j.pathophys.2007.02.001_bib44","doi-asserted-by":"crossref","first-page":"14313","DOI":"10.1074\/jbc.270.24.14313","article-title":"The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family","volume":"270","author":"Apte","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pathophys.2007.02.001_bib45","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.critrevonc.2003.09.008","article-title":"TIMPs as multifacial proteins","volume":"49","author":"Lambert","year":"2004","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.pathophys.2007.02.001_bib46","first-page":"323","article-title":"Tissue inhibitor of metalloproteinase-3 is a component of Bruch's membrane of the eye","volume":"150","author":"Farris","year":"1997","journal-title":"Am. J. Pathol."}],"container-title":["Pathophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928468008000059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928468008000059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,28]],"date-time":"2018-12-28T10:50:07Z","timestamp":1545994207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928468008000059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0928468008000059"],"URL":"https:\/\/doi.org\/10.1016\/j.pathophys.2007.02.001","relation":{},"ISSN":["0928-4680"],"issn-type":[{"value":"0928-4680","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}